The sensitivity and specificity of CA125 for early detection of ovarian cancer is improved when analysed in combination with novel biomarkers, although further validation studies are required to confirm the clinical utility of the multiplex assay.
Related Articles
Senza categoria
N E W S R O U N D
Cover Story
Vesna Kesic: exporting excellence in women’s cancers
Senza categoria